These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 31176377)
41. Chronic inflammatory demyelinating polyradiculoneuropathy with tumefactive central demyelination. Krivickas LS; Hochberg FH; Freeman S Muscle Nerve; 2006 Feb; 33(2):283-8. PubMed ID: 16086427 [TBL] [Abstract][Full Text] [Related]
42. Disease activity in chronic inflammatory demyelinating polyneuropathy: A comparative study of clinical and skin biopsy markers. Acarli ANÖ; Ünverengil G; Şirin NG; Çakar A; Durmuş H; Parman Y Muscle Nerve; 2022 Dec; 66(6):736-743. PubMed ID: 36151750 [TBL] [Abstract][Full Text] [Related]
43. Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses. Draak TH; Vanhoutte EK; van Nes SI; Gorson KC; Van der Pol WL; Notermans NC; Nobile-Orazio E; Lewis RA; Léger JM; Van den Bergh PY; Lauria G; Bril V; Katzberg H; Lunn MP; Pouget J; van der Kooi AJ; Hahn AF; van den Berg LH; van Doorn PA; Cornblath DR; Faber CG; Merkies IS; J Peripher Nerv Syst; 2015 Sep; 20(3):277-88. PubMed ID: 26110493 [TBL] [Abstract][Full Text] [Related]
44. Clinical correlates of fatigue in chronic inflammatory demyelinating polyneuropathy. Lawley A; Abbas A; Seri S; Rajabally YA Muscle Nerve; 2020 Aug; 62(2):226-232. PubMed ID: 32388856 [TBL] [Abstract][Full Text] [Related]
45. Optimization of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy evaluated by grip strength measurement. Kokubun N; Sada T; Yuki N; Okabe M; Hirata K Eur Neurol; 2013; 70(1-2):65-9. PubMed ID: 23796651 [TBL] [Abstract][Full Text] [Related]
46. Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity. De Sousa EA; Chin RL; Sander HW; Latov N; Brannagan TH J Clin Neuromuscul Dis; 2009 Jun; 10(4):163-9. PubMed ID: 19494726 [TBL] [Abstract][Full Text] [Related]
47. Cranial nerve involvement in typical and atypical chronic inflammatory demyelinating polyneuropathies. Shibuya K; Tsuneyama A; Misawa S; Suichi T; Suzuki Y; Kojima Y; Nakamura K; Kano H; Prado M; Kuwabara S Eur J Neurol; 2020 Dec; 27(12):2658-2661. PubMed ID: 32876980 [TBL] [Abstract][Full Text] [Related]
48. Fatigue in chronic inflammatory demyelinating polyneuropathy. Gable KL; Attarian H; Allen JA Muscle Nerve; 2020 Dec; 62(6):673-680. PubMed ID: 32710648 [TBL] [Abstract][Full Text] [Related]
49. Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study. Merkies IS; Hughes RA; Donofrio P; Bril V; Dalakas MC; Hanna K; Hartung HP; Latov N; van Doorn PA; Deng C; J Peripher Nerv Syst; 2010 Sep; 15(3):208-15. PubMed ID: 21040143 [TBL] [Abstract][Full Text] [Related]
50. Peripheral nerve ultrasound changes in CIDP and correlations with nerve conduction velocity. Di Pasquale A; Morino S; Loreti S; Bucci E; Vanacore N; Antonini G Neurology; 2015 Feb; 84(8):803-9. PubMed ID: 25632087 [TBL] [Abstract][Full Text] [Related]
51. Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database. Doneddu PE; Cocito D; Manganelli F; Fazio R; Briani C; Filosto M; Benedetti L; Mazzeo A; Marfia GA; Cortese A; Fierro B; Jann S; Beghi E; Clerici AM; Carpo M; Schenone A; Luigetti M; Lauria G; Antonini G; Rosso T; Siciliano G; Cavaletti G; Liberatore G; Santoro L; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Toscano A; Mataluni G; Piccolo L; Cosentino G; Sabatelli M; Nobile-Orazio E; J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):125-132. PubMed ID: 30297520 [TBL] [Abstract][Full Text] [Related]
52. Rituximab in refractory chronic inflammatory demyelinating polyneuropathy. Muley SA; Jacobsen B; Parry G; Usman U; Ortega E; Walk D; Allen J; Pasnoor M; Varon M; Dimachkie MM Muscle Nerve; 2020 May; 61(5):575-579. PubMed ID: 31922613 [TBL] [Abstract][Full Text] [Related]
53. Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Bozovic I; Kacar A; Peric S; Nikolic A; Bjelica B; Cobeljic M; Petrovic M; Stojanov A; Djuric V; Stojanovic M; Djordjevic G; Martic V; Dominovic A; Vukojevic Z; Basta I J Neurol; 2017 Dec; 264(12):2481-2486. PubMed ID: 29086018 [TBL] [Abstract][Full Text] [Related]
54. Prominent fatigue in spinal muscular atrophy and spinal and bulbar muscular atrophy: evidence of activity-dependent conduction block. Noto Y; Misawa S; Mori M; Kawaguchi N; Kanai K; Shibuya K; Isose S; Nasu S; Sekiguchi Y; Beppu M; Ohmori S; Nakagawa M; Kuwabara S Clin Neurophysiol; 2013 Sep; 124(9):1893-8. PubMed ID: 23643309 [TBL] [Abstract][Full Text] [Related]
55. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. Nasu S; Misawa S; Sekiguchi Y; Shibuya K; Kanai K; Fujimaki Y; Ohmori S; Mitsuma S; Koga S; Kuwabara S J Neurol Neurosurg Psychiatry; 2012 May; 83(5):476-9. PubMed ID: 22338030 [TBL] [Abstract][Full Text] [Related]
59. Diffusion tensor imaging can be used to detect lesions in peripheral nerves in patients with chronic inflammatory demyelinating polyneuropathy treated with subcutaneous immunoglobulin. Markvardsen LH; Vaeggemose M; Ringgaard S; Andersen H Neuroradiology; 2016 Aug; 58(8):745-52. PubMed ID: 27114080 [TBL] [Abstract][Full Text] [Related]
60. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Hughes RA; Donofrio P; Bril V; Dalakas MC; Deng C; Hanna K; Hartung HP; Latov N; Merkies IS; van Doorn PA; Lancet Neurol; 2008 Feb; 7(2):136-44. PubMed ID: 18178525 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]